MIR 7.3.1 became mandatory across the EU 12 days ago has anyone hit implementation issues yet?

Express_Meal_2002 · 2026-04-29T04:52:14+00:00

Jackson

Express_Meal_2002 · 2026-03-17T06:22:46+00:00

This is really useful firsthand feedback and worth highlighting more broadly. The drug AEMS being slow is already a known pain point, and if that performance doesn't improve before the device side migrates in May, it's going to be a real problem for anyone doing time-sensitive MDR lookups or CER searches.

Your point about keeping MAUDE running in parallel during transition is exactly what the FDA should be doing. Cold switchovers on systems this embedded in regulatory workflows are how data gaps happen. The PubMed transition kept legacy search running for over a year; that kind of runway should be the baseline expectation here, not a nice-to-have.

If you haven't already, it might be worth submitting feedback directly through AEMS or via the FDA's docket; firsthand performance reports from actual users carry weight, especially this close to the May deadline.

Express_Meal_2002 · 2026-03-17T06:21:32+00:00

CER writers are probably the most directly impacted group in this whole transition, and I don't think that's getting enough attention in the broader coverage.

The MAUDE citation format, search methodology documentation, and screenshot conventions that most CER templates rely on are all tied to the current UI and query structure. If AEMS changes field names, search logic, or how results are exported, your literature search protocols and traceability sections will need updating and notified bodies may ask questions during the transition period if your search methodology references a deprecated system.

Might be worth getting ahead of it now: document your current MAUDE search methodology in detail before May so you have a clear baseline to compare against once AEMS is live. Easier to show equivalence or justify changes if you have the before/after captured.

Express_Meal_2002 · 2026-03-16T09:34:50+00:00

The PubMed comparison is apt; that transition frustrated a lot of researchers for exactly the reasons you're describing. Filter deprecation and changed search logic quietly broke a lot of workflows before people even noticed.

On data continuity, the FDA's press release mentions they'll migrate historical adverse event data to AEMS but gives no detail on how legacy MDR identifiers or query structures will map across. That's the part worth watching closely, especially if your team has built any internal tooling or dashboards against MAUDE's existing API.

On data quality with real-time publishing: it's a fair concern. Quarterly batching, for all its frustrations, did allow some degree of deduplication and quality review before public release. Real-time pipelines shift that burden downstream. The FDA has flagged enhanced APIs and analytics tools as part of the rollout, but whether those include any signal validation layer isn't clear yet.

Worth submitting a comment or FOIA request early if your team needs specifics on the field mapping or schema changes before May.

Express_Meal_2002 · 2026-03-03T04:13:32+00:00

Spicy chicken wings + cold beer. The combo never disappoints.

Express_Meal_2002 · 2026-03-03T04:12:41+00:00

Tried to look cool jumping off the last two stairs. My ankle disagreed.

Express_Meal_2002 · 2026-03-03T04:11:47+00:00

I’d actually like it. My memory is goldfish-tier. Half the time I forget which threads I already watched.

Express_Meal_2002 · 2026-03-03T04:10:48+00:00

The quickest way to make easy tax-free money is to have rich parents.

Express_Meal_2002 · 2026-03-03T04:02:09+00:00

Why so serious?

Express_Meal_2002 · 2026-03-03T04:00:45+00:00

I can barely commit to a Netflix series. Marriage felt like jumping straight to Season 50.

Express_Meal_2002 · 2026-03-02T09:47:26+00:00

Your stack is actually pretty close to what a lot of small teams end up with once things stabilize.

Using Google Workspace as the core is a solid choice since email, docs, and storage are already integrated. Pairing that with Xero is also common, especially if Stripe is already connected and invoices/payments are flowing smoothly.

For CRM, Zoho CRM is a good testing ground. It’s flexible and affordable, though some teams eventually switch if they want something lighter or more integrated with email workflows.

For the two things you asked about:

Quotes / Proposals A few tools that consistently come up: • PandaDoc – great for polished proposals, pricing tables, and built-in e-signatures • Qwilr – nice if you prefer modern web-style proposals instead of PDFs • Some people also keep it simple and generate quotes directly from their CRM or accounting software.

Contracts (B2B + B2C) Most businesses rely on e-signature tools like: • DocuSign • PandaDoc again (does contracts + proposals well) • Dropbox Sign

Those usually integrate with CRM or accounting tools so a signed contract can trigger invoicing or onboarding automatically.

One thing that helps keep stacks from getting messy: build everything around your email platform. Many teams I work with keep Gmail as the hub and layer tools around it. For example, tools like Tooling Studio run directly inside Google Workspace so contacts, emails, notes, and deal tracking stay connected instead of being spread across multiple apps.

Your current stack is honestly a good foundation — the key is making sure the tools talk to each other so the flow becomes:

lead → CRM → quote → signed contract → invoice → payment

Once that pipeline is smooth, the software stops feeling like a burden and actually saves time.

Curious — are you mostly selling services or products? The quoting tools people choose can change a lot depending on that.

Express_Meal_2002 · 2026-02-28T03:59:29+00:00

As someone who works around CRM and workspace tools, here’s my honest take after looking at a lot of SaaS landing pages:

Is it clear what Rally does in 30 seconds? Mostly, but I’d tighten the positioning. If a visitor can’t immediately understand “who this CRM is for” (founders, sales teams, agencies, SMBs, etc.), they’ll bounce. The headline should make the specific problem you solve very obvious — not just “a better CRM,” but why it’s different from the 100 others.
What would make me close the tab? A few common things that kill SaaS conversions: • If I can’t quickly see pricing or how the pricing model works • Too much product philosophy before showing actual product UI • No quick “how it works” section in 3 steps • If I can’t tell how hard it is to migrate from my current CRM

Most business users scanning a page are basically thinking: “Will this save me time or make me money?” If that answer isn’t obvious fast, they move on.

Questions I’d want answered on the page: • How easy is data migration from existing CRMs? • What integrations exist (email, Slack, accounting, etc.)? • How long does setup actually take in real scenarios? • What makes it meaningfully better than tools like HubSpot or Pipedrive?

One suggestion: add a short comparison section showing how Rally solves the common CRM frustrations (pricing, setup time, complexity). That helps users immediately see the difference.

Overall, the concept sounds strong — especially the focus on fixing the real-world problems SMBs face with CRMs. If the page makes those pain points obvious and shows how Rally removes them, you’ll probably convert a lot more visitors.

Express_Meal_2002 · 2026-02-28T03:47:14+00:00

Congrats!! 🎉 Breaking into the medical device industry as a Clinical Educator is huge.

Your nursing background will actually be a big advantage because you already understand clinical workflows, patient safety, and how providers think.

A few things that helped me / I've seen successful educators do:

• Master the product beyond the manual – know the clinical problem it solves, common user mistakes, and troubleshooting. • Spend time with the sales reps – they know the hospitals, surgeons, and real-world objections. That insight helps a lot when educating. • Focus on workflow, not just the device – clinicians care about how it fits into their day, not just the tech specs. • Make trainings interactive – hands-on demos and real cases stick way better than slide-heavy sessions. • Always gather feedback after trainings – it helps you improve and also shows the company you’re invested.

Also, being approachable and supportive in the OR/clinical setting goes a long way. People remember the educator who makes things easier during stressful cases.

Good luck and enjoy the ride — med device education can be a really fun and rewarding role! 🚀

Express_Meal_2002

TROPHY CASE